When Cost-Sharing Waivers for COVID-19 Treatment Expire for People with Private Insurance Plans August 24, 2020 Slide About 88% – nearly nine in ten – enrollees in the individual and fully-insured group markets are covered by plans that have taken action to limit out-of-pocket costs for patients undergoing treatment for COVID-19 since the start of the pandemic. However, after accounting for waivers that have already expired (20%) or are scheduled to expire by the end of September (16%), just over half of enrollees in these plans will still be eligible for waived cost-sharing in October and beyond.
What Are the Prescription Drug Provisions in the Inflation Reduction Act? September 15, 2022 Slideshow
Long-Term Care Facility Costs Are the Largest Share of Annual Out-of-Pocket Spending by Medicare Beneficiaries January 17, 2020 Slide Long term care facility costs are the largest share of annual out of pocket spending by Medicare beneficiaries — representing 32% of their spending on services annually.
Among the 10 Antiretrovirals with the Highest Part D Spending in 2017, All Had List Price Increases Exceeding Inflation December 18, 2019 Slide
Almost Three-Quarters of Antiretrovirals Covered by Medicare Part D Had List Price Increases Above Inflation Between 2016 and 2017 December 18, 2019 Slide
Most Antiretrovirals Covered by Medicare Part D (as of 2017) Are Brand-Name, Single Source Medications December 18, 2019 Slide
